- Research Article
- Open Access
Transcriptional activity of the RHOB gene is influenced by regulatory polymorphisms in its promoter region
Genomic Medicine volume 1, pages125–128 (2007)
Osteoarthritis (OA) is a chronic joint disease with genetic as well as environmental factors contributing to its etiology. We recently identified RHOB as a gene overexpressed in osteoarthritis. Interestingly, RHOB harbors numerous polymorphisms in its promoter region and genotyping of OA patients and healthy controls revealed an association of the single nucleotide polymorphism (SNP) rs585017 with the disease. We here set out to investigate the influence of RHOB promoter polymorphisms on the transcriptional activity of the gene and we found evidence that the SNPs rs2602160 and rs585017 cooperate in regulating RHOB expression. In addition, a variable number of tandem repeats (VNTR) impacts on the RHOB transcriptional activity in a cell type restricted manner. These results mechanistically link our previous finding of an elevated RHOB expression to the disease associated SNP rs585017 and confirm a role for regulatory polymorphisms in osteoarthritis.
Osteoarthritis (OA, [MIM 165720]) is the most prevalent joint disease in the elderly and considered a complex disease including genetic as well as environmental components (Buckwalter et al. 2004; Hunter et al. 2002). It is characterized by the complete loss of articular cartilage, leaving the affected joints functionally impaired. In the last decade, several genetic susceptibility factors were identified, among them regulatory gene polymorphisms in the IL-1 locus (Moos et al. 2000; Spector and MacGregor 2004). We recently described the gene RHOB (MIM 165370) as a novel susceptibility gene for OA (Mahr et al. 2006). RHOB was overexpressed in OA patients compared to healthy controls and genotyping of larger cohorts revealed a disease association of the G allele of the SNP rs585017 located at position −165 in the RHOB promoter. RHOB encodes a small GTPase involved in a broad range of cellular activities, e.g. actin organization, vesicular transport, stress response, and apoptosis (Prendergast 2001; Ridley 2001). Sequence analysis of the RHOB promoter region revealed the presence of additional polymorphisms including several SNPs (unpublished data) and a VNTR sequence (Tovar et al. 2003). We here used Luciferase reporter assays to investigate RHOB promoter polymorphisms for their functional impact on transcriptional regulation.
Materials and methods
Genotyping of the VNTR polymorphism was performed on 147 OA patients undergoing joint replacement surgery and 179 healthy controls. Details about study subjects are published elsewhere (Mahr et al. 2006). The study was approved by the local ethical committee and appropriate informed consent was obtained from all human subjects.
Both, the chondrosarcoma line SW1353 and HeLa cells were maintained in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal calf serum (FCS) and 1% penicillin/streptomycin (Invitrogen). For transient transfections, cells were grown in 6-well-plates at a concentration of 1 × 106cells per well using 2 ml DMEM supplemented with 10% FCS without antibiotics.
Genotyping of the VNTR polymorphism
The VNTR polymorphism was genotyped via genomic polymerase chain reaction (PCR) using the primers 5′-tcggttgacttgggtctttc-3′ (forward) and 5′-cactatgaactctgatcccg-3′ (reverse) followed by electrophoretical separation on a 3% NuSieve® 3:1 agarose gel (Biozym).
Sequencing analysis was done as described previously (Mahr et al. 2006).
Analysis of transcriptional activity
Two 5′-flanking regions of RHOB (−1469 to −1223 and −1224 to + 109) harboring the respective SNPs rs2602160 and rs585017 as well as the VNTR element were prepared by PCR. Genomic DNA containing the CC or TT genotype at −1285 bp and the genotype AA or GG at −165 bp from the transcription start site was used as a PCR template. For amplification of the most 5′ region, the primers 5′-nnnnn-acgcgtcaccttcctgcttgtgttca−3′ (forward) containing a MluI restriction site and 5′-tagaatccaaccaccccaag-3′ (reverse) were used. The region from −1224 to +109 was amplified using the primers 5′-tagaggggacaccccctaac-3′ (forward) and 5′-nnnnnagatct-ctcccgggtctctccg-3′ (reverse) containing a BglII restriction site. The PCR products were inserted into the luciferase reporter vector pGL3-enhancer (Promega). We combined the different genotypes of the SNPs rs2602160 and rs585017 using a NheI restriction site. SW1353 cells and HeLa cells were transiently transfected using 4 μl FuGENE HD and 400 ng of the pGL3-construct. Cells were cotransfected with 25 ng of a constitutively active Renilla luciferase vector (pRL-TK) and firefly luciferase activity was normalized to Renilla luciferase activity. A total of 24 h after transfection, cells were lysed using 500 μl Passive Lysis Buffer (Promega). Luciferase activities from firefly or Renilla were measured using a Dual-Glo Luciferase Assay System (Promega) and the luminometer Lumat LB 9501 (Bertold).
Student’s t-test including Welch’s correction was used to determine the significance of differences in the luciferase reporter assays.
Cooperative regulation of promoter SNPs
Sequence analyses of the RHOB promoter regions of six OA patients and six healthy controls confirmed the presence of SNPs at positions −165 (rs585017) and at −1285 (rs2602160) (Fig. 1a). Interestingly, both SNPs showed an identical distribution suggesting the possibility of linkage disequilibrium. To test whether the OA associated SNP at −165 itself or the one at −1285 influence the transcriptional activity of RHOB, four different luciferase constructs were established carrying either the wildtype-haplotype (pGL3-TA), mixed haplotypes (pGL3-TG and pGL3-CA), or the SNP-haplotype (pGL3-CG). All four constructs were analyzed in the chondrocyte-like cell line SW1353 and in HeLa cells and the results show that the SNP-haplotype (pGL3-CG) yielded a significantly higher transcriptional activity compared to the wildtype-haplotype (pGL3−TA) withP-values of 0.008 and 0.02 in SW1353 and HeLa cells, respectively (Fig. 1b, c). Interestingly, neither the rs2602160 C allele nor the rs585017 G allele by themselves were able to influence the transcriptional activity of RHOB (data not shown). Out data therefore suggest that the rs2602160 and rs585017 promoter SNPs cooperate in regulating the transcriptional activity of RHOB.
Cell type-restricted regulation of the VNTR polymorphism
The human RHOB promoter also harbors a VNTR polymorphism which is located 820 bp upstream of the transcriptional start site and which carries between 8 and 14 numbers of a 34 bp tandem repeat (Fig. 1a) (Tovar et al. 2003). To test if OA patients and healthy controls differ in their VNTRs, we analyzed larger cohorts via PCR amplification. For both healthy controls and OA patients the most frequently carried number of TR was 10 and there was no statistically significant difference in the distribution between both groups (Table 1). However, we did find a statistically significant increase in G alleles of rs585017 in patients carrying 10 TR compared to carriers of any other number of TR (data not shown). To test, if the VNTR influences the transcriptional activity under the control of the RHOB wildtype-haplotype promoter, we established 2 different reporter constructs harboring either a short VNTR element with 9 (pGL3-9TR) or a long element with 13 repeats (pGL3-13TR). Interestingly, the long promoter construct pGL3-13TR revealed a significantly higher transcriptional activity in SW1353 cells compared with the short construct pGL3-9TR. TheP-value of 0.007 indicates statistical significance (Fig. 2a) however, these results could not be confirmed in HeLa cells suggesting a cell type restricted regulatory mechanism (Fig. 2b).
In the present study we demonstrate that the promoter SNPs rs585017 and rs2602160 cooperate in increasing the transcriptional activity of RHOB in both, a chondrosarcoma line and in HeLa cells. The VNTR sequence located 820 bp upstream of the transcriptional start site also influences RHOB expression in that an elevated number of TR increases the transcriptional activity. However, this latter regulation is restricted to the chondrosarcoma line.
The synergistic effect of the promoter SNPs is likely to be provoked by conformational changes in the secondary structure of the DNA which in turn may modify the binding of transcription factors. Indeed, the presence of the rs2602160 SNP-haplotype generates a consensus recognition site for the nuclear factor 1 (NF-1) which is absent in the presence of the wildtype-haplotype. We did not find obvious transcription factor binding sites at rs585017 however, there may be cooperative binding of transcription factors which is also dependent on a conformational change at −165.
Genotype analyses revealed no association of the VNTR polymorphism with OA. However, we here show that a VNTR sequence carrying 13 repeats increases the transcriptional activity of RHOB compared to a VNTR with only 9 repeats. Our findings may seem contradictory to what has been published before (Tovar et al. 2003): Tovar et al. analyzed the effect of the VNTR sequence in combination with the SV40 promoter and did not find an impact of the number of repeats on the transcriptional activity. We here investigated the VNTR in combination with its native RHOB promoter and we used the chondrocyte-like SW1353 and HeLa cells while it was human MCF7 cells in the Tovar study. As both HeLa and MCF7 cells are of epithelial origin, a cell type restricted regulation of the VNTR polymorphism on RHOB gene expression is likely.
RHOB encodes a small GTPase which is involved in a broad range of cellular processes like vesicular transport, actin organization and apoptosis (Prendergast 2001; Ridley 2001) and indeed, we recently described a significant increase of apoptosis in RHOB overexpressing chondrocyte-like SW1353 cells (Mahr et al., submitted manuscript). Our data in combination with published reports describing significant apoptosis of the articular chondrocytes during OA (Blanco et al. 1998; Thomas et al. 2007) point at a functional role of RHOB overexpression in OA pathogenesis. Because OA is a disease of the elderly, we speculate that even a slightly enhanced RHOB expression over decades would influence the physiology of the articular chondrocytes leading to cell death and a loss of articular cartilage.
Taken together our data indicate that both the SNPs and the VNTR within the promoter region of the RHOB gene are true regulatory polymorphisms which via differential expression contribute to OA pathogenesis.
Here, we describe the synergistic effect of two single nucleotide polymorphisms in increasing the transcriptional activity of the gene RHOB previously described to be associated with osteoarthritis. Additionally, we found that a VNTR sequence also influences RHOB expression in that an elevated number of tandem repeats increases the transcriptional activity. Together, our data indicate that both the SNPs and the VNTR are true regulatory polymorphisms which via differential expression of the RHOB gene contribute to osteoarthritis pathogenesis.
Single nucleotide polymorphism
Polymerase chain reaction
Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ et al (1998) Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum 41(2):284–289
Buckwalter JA, Saltzman C, Brown T (2004) The impact of osteoarthritis:implications for research. Clin Orthop Relat Res 427 Suppl:S6–S15
Hunter DJ, March L, Sambrook PN (2002) Knee osteoarthritis: the influence of environmental factors. Clin Exp Rheumatol 20:93–100
Mahr S, Burmester GR, Hilke D, Göbel U et al (2006) Cis- and trans-acting gene regulation is associated with osteoarthritis. Am J Hum Genet 78(5):793–803
Mahr S, Jonas L, Lorenz P, Müller B. Overexpression of RHOB promotes apoptosis in the chondrocyte-like cell line SW1353 (manuscript submitted)
Moos V, Rudwaleit M, Herzog V, Höhlig K et al (2000) Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritis. Arthritis Rheum 43:2417–2422
Prendergast GC (2001) Actin’ up: RhoB in cancer and apoptosis. Nat Rev Cancer 1(2):162–168
Ridley AJ (2001) Rho family proteins: coordinating cell responses. Trends Cell Biol 11(12):471–477
Spector TD, MacGregor AJ (2004) Risk factors for osteoarthritis:genetics. Osteoarthritis Cartilage 12 Suppl A:S39–S44
Thomas CM, Fuller CJ, Whittles CE, Sharif M (2007) Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthritis Cartilage 15(1):27–34
Tovar D, Faye JC, Favre G (2003) Cloning of the human RHOB gene promoter: characterization of a VNTR sequence that affects transcriptional activity. Genomics 81:525–530
This work was supported by grants from the Deutsche Forschungsgemeinschaft (Mu-844/9-1). The authors are grateful to Peter Lorenz for help with the luciferase reporter assays and to Robert Goertsches for help with the statistics.